Zynerba Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2014 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Zynerba Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2014 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 53.9M shares, a 22.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 53.9M +10M +22.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 53.5M +10.2M +23.5% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 47.9M +6.68M +16.2% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 47.1M +5.78M +14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 43.9M +2.68M +6.51% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 43.3M +2.07M +5.02% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 41.2M +11.2M +37.5% Dec 31, 2021 10-K 2023-03-28
Q3 2021 41.3M +11.8M +40.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 41.3M +12M +41% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 41.3M +17.7M +75% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 30M +6.76M +29.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 29.4M +6.25M +26.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 29.3M +6.06M +26.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 23.6M +2.5M +11.9% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 23.2M +5.58M +31.7% Dec 31, 2019 10-K 2021-03-10
Q3 2019 23.2M +5.57M +31.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 23.2M +9.64M +71.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 21.1M +7.51M +55.4% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 17.6M +4.07M +30.1% Dec 31, 2018 10-K 2020-03-10
Q3 2018 17.6M +4.37M +32.9% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 13.6M +304K +2.29% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 13.6M +347K +2.62% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 13.6M +3.56M +35.6% Dec 31, 2017 10-K 2019-03-11
Q3 2017 13.3M +3.63M +37.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 13.3M +4.06M +44.1% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 13.2M +4.01M +43.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 9.99M +795K +8.64% Dec 31, 2016 10-K 2018-03-12
Q3 2016 9.63M +428K +4.66% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 9.2M +7.17M +353% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 9.2M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 9.2M +7.17M +353% Dec 31, 2015 10-K 2017-03-27
Q3 2015 9.2M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 2.03M Jun 30, 2015 10-Q 2015-08-27
Q4 2014 2.03M Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.